Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies
- 15 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 51 (6), 1120-1128
- https://doi.org/10.1093/rheumatology/ker516
Abstract
Objectives. To compare the prevalence of and predictors for sustained drug-free remission in two cohorts of patients with recent-onset RA treated with DAS-driven therapy or non-DAS-driven therapy.Keywords
This publication has 20 references indexed in Scilit:
- The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt studyAnnals Of The Rheumatic Diseases, 2011
- Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchAnnals Of The Rheumatic Diseases, 2010
- Treating rheumatoid arthritis to target: recommendations of an international task forceAnnals Of The Rheumatic Diseases, 2010
- Tight control for the management of RA—a therapeutic approach worth pursuingNature Clinical Practice Rheumatology, 2008
- Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)Annals Of The Rheumatic Diseases, 2007
- Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity scoreAnnals Of The Rheumatic Diseases, 2007
- Long‐term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta‐analysisArthritis Care & Research, 2006
- Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialThe Lancet, 2004
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- The Effectiveness of Early Treatment with “Second-Line” Antirheumatic DrugsAnnals of Internal Medicine, 1996